John Pippen
Medical Oncology · Dallas, TXNPI 1649213521
Payments from drug & device makers
Across 17 payments — averaging $17,815 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$299K
- Pfizer$3K
- Athenex Pharmaceutical Division, LLC$350
- Puma Biotechnology, Inc.$64
- AstraZeneca$38
- Takeda Pharmaceuticals U.S.A., Inc.$23
- plus $97 from 7 others
What the payments were for
- Speaking & faculty fees$3,20091%
- Food & beverage$2968%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 2 | $299,359 |
| Pfizer | 2 | $2,923 |
| Athenex Pharmaceutical Division, LLC | 2 | $350 |
| Puma Biotechnology, Inc. | 1 | $64 |
| AstraZeneca | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Sanofi | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $13 |
| Amgen | 1 | $12 |
| Gilead | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TALZENNA$2,850
How this compares
$302,855 in reported general payments places this provider in the 65th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Sawsan RashdanDallas$29.9M
- David GerberDallas$22.8M
- Joyce O'ShaughnessyDallas$20.8M
- Moshe LevyDallas$19.7M
- Minal BarveDallas$16.7M
- Andrew PaulsonDallas$11.5M
- Hans HammersDallas$11.4M
- James StraussDallas$9.1M
- Larry AndersonDallas$8.7M
- Heather McArthurDallas$7.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.